Follow Us:

US FDA

Home FDA Medical Device Classification
FDA Medical Device Classification

FDA Medical Device Classification

FDA medical device classification consists of three distinct classes based on the level of risk they pose to patients and users. Each device class requires a different level of regulatory controls to ensure the safety and effectiveness of the device. Understanding these classifications is important for manufacturers / Initial exporters / initial importers/specification developers seeking FDA clearance.

 

The FDA medical device and in-vitro diagnostic device classification is different from the European classification.

For reliable, cost-effective, and fast services related to US FDA Medical Device classification and device compliance, get in touch with us.

FDA Medical Device Classification Specialties

Anesthesiology, Cardiovascular, Chemistry, Dental, Ear, nose and throat, Gastroenterology and urology, General and plastic surgery, General Hospital, Hematology, Immunology, Microbiology, Neurology, Obstetrical and gynaecological, Ophthalmic, Orthopedic, Pathology, Physical Medicine, Radiology, Toxicology are the major  Specialties in FDA Medical Device Classification

Key Factors of US FDA Medical Device Classification?

  1. Intended Use: The purpose for which the device is intended, including diagnosis, treatment, monitoring, or prevention.
  2. Indications for Use disease or condition the medical device will diagnose, treat, prevent, cure, or mitigate, including a description of the target patient population.
  3. Risk Level: The level of risk the device poses to the patient or user.
  4. Regulatory Pathway: Devices are classified based on the data required to prove their safety and effectiveness.

How Medical Device Classified by US FDA?

The US FDA has classified medical devices into three classes. They are Class I, Class II, and Class III, and each corresponds to increasing levels of risk

Class I - Low Risk (General Controls)

Class I devices are considered to pose the lowest risk to patients and users. Most of the class 1 devices are exempt from the 510(k) clearance process, though some may still require 510(k) clearance for selling in the USA.

 

Examples of Class 1 devices that are exempt from 510(k) include bandages, tongue depressors, manual stethoscopes, and non-powered wheelchairs. However, certain devices like examination gloves still require 510(k) clearance despite being classified as Class 1.

 

The regulatory controls established by the FDA for class 1 devices are the following

  • Establishment Registration and Device Listing
  • US Agent for Foreign manufactures
  • Labelling
  • Reporting of adverse events or malfunctions
  • Compliance with FDA regulations on GMP (21 CFR 820) superseded with QMSR now

 

Most class I devices are not required to submit a 510(k), making them easier to sell in the USA market.

Class II - Moderate Risk (General & Special Controls)

Class II devices pose a higher risk than class I devices and require special controls in addition to general controls. Most Class II devices require 510(k) clearance which involves demonstrating that the device is substantially equivalent to an already legally marketed device (known as a predicate device).

 

Examples of Class II devices are  Powered wheelchairs, surgical drapes, infusion pumps, and diagnostic imaging devices.

 

The regulatory controls (Special Controls) established by the FDA for class II devices are the following

  • Performance standards
  • Post-market surveillance
  • Special labelling requirements
  • Clinical performance data
  • Establishment Registration and Device Listing
  • US Agent for Foreign manufactures
  • Reporting of adverse events or malfunctions
  • Compliance with FDA regulations on GMP (21 CFR 820) superseded with QMSR now

 

A 510(k) clearance is required for Class II devices unless the device is specifically exempt. This submission demonstrates that the new device is equivalent to a predicate device already on the market.

Class III - High Risk (General Controls & PMA)

Class III devices possess the highest risk are mainly used to sustain or support life, and are implanted. These devices require Premarket Approval (PMA) from the FDA to demonstrate safety and effectiveness.

 

Examples of Class III devices are Implantable pacemakers, heart valves, and breast implants.

 

The regulatory controls follow Premarket Approval (PMA), requiring clinical trial data to ensure the device’s safety and effectiveness. The FDA closely scrutinizes these devices because they are crucial in life-supporting or high-risk medical scenarios.

FDA CLASSIFICATION

FDA Classification and Regulatory Pathways for Device Approvals

The FDA 510(k) or the premarket approval process.

This is the most common route for Class I and Class II device approval. A manufacturer or specification developer must demonstrate that the device is substantially equivalent to a predicate device already on the market. Stringent clinical trials may not be required in most cases.

 

The FDA PMA or Premarket Approval Process

For Class III devices, Premarket Approval (PMA) is required. This process involves clinical testing and a full scientific review by the FDA to prove that the device is safe and effective for its intended use.

 

The De Novo Classification process

This pathway is used for devices that are novel and do not have a predicate device for comparison. If the device is low to moderate risk, the FDA may grant a De Novo classification, which assigns the device to Class I or II, thus avoiding the need for a PMA.

Note:

  • If your product is found to be “exempt,” just general regulations apply, and no formal FDA submission is necessary. You must, however, register your business with the FDA and then list the product.
  • If you discover that your product requires specific controls, you will need to prepare a 510(k) filing to the FDA and obtain clearance before coming to market. Following that, you must register your business and list the product.
  • If your product requires premarket approval, you must follow the FDA PMA process to obtain permission before going to market.